🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
This is an open-label, multi-center, non-randomized study of the safety and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00934856
Treatments Being Tested
In HER2-positive metastatic breast cancer, trastuzumab based treatment is t...
Status
Completed
Location
Hopital Sud - Amiens
Start Date
2013-03-03
Trial ID
NCT01835236
Treatments Being Tested
The purpose of this trial is to evaluate efficacy and toxicity of either th...
Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Start Date
2014-11
Trial ID
NCT02568839
Treatments Being Tested
A Prospective, Multicenter, Non-Interventional Study of Primary Data Collec...
Status
Completed
Location
Instituto Alexander Fleming
Start Date
2020-02-21
Trial ID
NCT04158258
Treatments Being Tested
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
A national, prospective, multi-center, open-label, multi-cohort study compr...
Status
Recruiting
Location
Soonchunhyang University Hospital Bucheon
Start Date
2022-09-28
Trial ID
NCT05525858
Anti-HER2 therapy, such as trastuzumab and pertuzumab, has significantly im...
Status
Active Not Recruiting
Location
Natera
Start Date
2024-04-01
Trial ID
NCT06663787
Treatments Being Tested
ADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patie...
Status
Recruiting
Location
Klinikum Mittelbaden, Brustzentrum
Start Date
2024-02-05
Trial ID
NCT05704829
Treatments Being Tested